Muramatsu T - Search Results

1

miR-544a induces epithelial-mesenchymal transition through the activation of WNT signaling pathway in gastric cancer.

Yanaka Y, Muramatsu T, Uetake H, Kozaki K, Inazawa J. Yanaka Y, et al. Among authors: muramatsu t. Carcinogenesis. 2015 Nov;36(11):1363-71. doi: 10.1093/carcin/bgv106. Epub 2015 Aug 11. Carcinogenesis. 2015. PMID: 26264654

2

Overexpression of SMYD2 relates to tumor cell proliferation and malignant outcome of esophageal squamous cell carcinoma.

Komatsu S, Imoto I, Tsuda H, Kozaki KI, Muramatsu T, Shimada Y, Aiko S, Yoshizumi Y, Ichikawa D, Otsuji E, Inazawa J. Komatsu S, et al. Among authors: muramatsu t. Carcinogenesis. 2009 Jul;30(7):1139-46. doi: 10.1093/carcin/bgp116. Epub 2009 May 7. Carcinogenesis. 2009. PMID: 19423649

3

Frequent silencing of protocadherin 17, a candidate tumour suppressor for esophageal squamous cell carcinoma.

Haruki S, Imoto I, Kozaki K, Matsui T, Kawachi H, Komatsu S, Muramatsu T, Shimada Y, Kawano T, Inazawa J. Haruki S, et al. Among authors: muramatsu t. Carcinogenesis. 2010 Jun;31(6):1027-36. doi: 10.1093/carcin/bgq053. Epub 2010 Mar 3. Carcinogenesis. 2010. PMID: 20200074

4

YAP is a candidate oncogene for esophageal squamous cell carcinoma.

Muramatsu T, Imoto I, Matsui T, Kozaki K, Haruki S, Sudol M, Shimada Y, Tsuda H, Kawano T, Inazawa J. Muramatsu T, et al. Carcinogenesis. 2011 Mar;32(3):389-98. doi: 10.1093/carcin/bgq254. Epub 2010 Nov 26. Carcinogenesis. 2011. PMID: 21112960

5

Stabilization of phenotypic plasticity through mesenchymal-specific DNA hypermethylation in cancer cells.

Kurasawa Y, Kozaki K, Pimkhaokham A, Muramatsu T, Ono H, Ishihara T, Uzawa N, Imoto I, Amagasa T, Inazawa J. Kurasawa Y, et al. Among authors: muramatsu t. Oncogene. 2012 Apr 12;31(15):1963-74. doi: 10.1038/onc.2011.373. Epub 2011 Aug 29. Oncogene. 2012. PMID: 21874048

6

Integrative array-based approach identifies MZB1 as a frequently methylated putative tumor suppressor in hepatocellular carcinoma.

Matsumura S, Imoto I, Kozaki K, Matsui T, Muramatsu T, Furuta M, Tanaka S, Sakamoto M, Arii S, Inazawa J. Matsumura S, et al. Among authors: muramatsu t. Clin Cancer Res. 2012 Jul 1;18(13):3541-51. doi: 10.1158/1078-0432.CCR-11-1007. Epub 2012 May 9. Clin Cancer Res. 2012. PMID: 22573353

7

Potential of tumor-suppressive miR-596 targeting LGALS3BP as a therapeutic agent in oral cancer.

Endo H, Muramatsu T, Furuta M, Uzawa N, Pimkhaokham A, Amagasa T, Inazawa J, Kozaki K. Endo H, et al. Among authors: muramatsu t. Carcinogenesis. 2013 Mar;34(3):560-9. doi: 10.1093/carcin/bgs376. Epub 2012 Dec 10. Carcinogenesis. 2013. PMID: 23233740

8

miR-655 Is an EMT-suppressive microRNA targeting ZEB1 and TGFBR2.

Harazono Y, Muramatsu T, Endo H, Uzawa N, Kawano T, Harada K, Inazawa J, Kozaki K. Harazono Y, et al. Among authors: muramatsu t. PLoS One. 2013 May 14;8(5):e62757. doi: 10.1371/journal.pone.0062757. Print 2013. PLoS One. 2013. PMID: 23690952 Free PMC article.

9

Chromothripsis-like chromosomal rearrangements induced by ionizing radiation using proton microbeam irradiation system.

Morishita M, Muramatsu T, Suto Y, Hirai M, Konishi T, Hayashi S, Shigemizu D, Tsunoda T, Moriyama K, Inazawa J. Morishita M, et al. Among authors: muramatsu t. Oncotarget. 2016 Mar 1;7(9):10182-92. doi: 10.18632/oncotarget.7186. Oncotarget. 2016. PMID: 26862731 Free PMC article.

10

Significant impact of miRNA-target gene networks on genetics of human complex traits.

Okada Y, Muramatsu T, Suita N, Kanai M, Kawakami E, Iotchkova V, Soranzo N, Inazawa J, Tanaka T. Okada Y, et al. Among authors: muramatsu t. Sci Rep. 2016 Mar 1;6:22223. doi: 10.1038/srep22223. Sci Rep. 2016. PMID: 26927695 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,707 results

Search Page